Buy Crypto Markets Spot FuturesZEC Earn Event Center Rewards Hub

Avadel Pharmaceuticals plc (AVDL)

NASDAQ

$--

(--)

Market Closed

Avadel Pharmaceuticals plc (AVDL) Live Price Chart

Last updated: ⁦2026-09-09 05:05:20⁩. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.

Summary

Avadel Pharmaceuticals plc (AVDL) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at --, with a market capitalization of -- and a P/E ratio of --. Over the past 52 weeks, its price has ranged from -- to --. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	--
Open	--
Day's High	--
Day's Low	--
Previous Close	--
Volume	--
Average Volume	--
P/E Ratio	--
52-Week High	--
52-Week Low	--
Dividend Yield	--
Earnings Date	--

Avadel Pharmaceuticals plc (AVDL) Latest Closing Stock Price

Avadel Pharmaceuticals plc (AVDL) last closed at $-- as of --, -- from the previous close of $--.

During the latest regular trading session, AVDL traded between $-- and $--, with a volume of -- shares. The closing price was -- and --.

Avadel Pharmaceuticals plc (AVDL) 7-Day Stock Price Change

Over the past seven days, Avadel Pharmaceuticals plc (AVDL) moved from $21.56 to $21.64, representing a gain of 0.37% ($0.08).

The stock traded between $21.55 and $21.76 during the period. The latest price is near the middle of the 7-day range, indicating range-bound.

The average daily volume was 6.51 million shares, up versus the previous seven-day period, indicating higher trading activity.

What is Avadel Pharmaceuticals plc (AVDL)?

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.

Avadel Pharmaceuticals plc Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	188
Exchange	NASDAQ
Company Website	https://www.avadel.com

How to Buy Avadel Pharmaceuticals plc (AVDL) Stock on MEXC

Eligible investors can buy real shares of Avadel Pharmaceuticals plc (AVDL) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for AVDL and Place Your Order

Open the RealStocks trading page and search for AVDL. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Avadel Pharmaceuticals plc (AVDL) stock price today?

Avadel Pharmaceuticals plc (AVDL) is currently trading at --, -- from the previous close of --. Intraday prices update in real time during regular trading hours.

2.Is AVDL stock going up or down today?

As of --, AVDL is trading at --, -- from its previous close of --. The stock has traded between -- and -- during today’s regular session. Past price movements do not guarantee future results.

3.What is AVDL pre-market price?

As of --, AVDL is trading at -- in pre-market trading, -- from the previous close of --. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is AVDL after-hours price?

As of --, AVDL is trading at -- in after-hours trading, -- from the regular-session close of --. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is AVDL stock trading now?

AVDL trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does AVDL sit relative to its 52-week high and low?

Over the past 52 weeks, AVDL has traded between a low of -- and a high of --. At --, the stock is positioned --% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Avadel Pharmaceuticals plc in?

Avadel Pharmaceuticals plc (AVDL) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Avadel Pharmaceuticals plc's market capitalization and where is it listed?

Avadel Pharmaceuticals plc is listed on the NASDAQ exchange with a market capitalization of --. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is AVDL valued in terms of P/E ratio and EPS?

AVDL trades at a P/E ratio of --, based on trailing-twelve-month EPS of --. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Avadel Pharmaceuticals plc pay a dividend?

Avadel Pharmaceuticals plc pays an indicated annual cash dividend of -- per share, with a current dividend yield of --% based on the latest share price. Dividend policies are subject to change at the board's discretion.